Published in Virology on December 05, 2005
Cellular and molecular mechanisms of liver injury. Gastroenterology (2008) 3.02
Molecular mechanisms of hepatic apoptosis. Cell Death Dis (2014) 1.21
Apoptosis in animal models of virus-induced disease. Nat Rev Microbiol (2009) 1.19
Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol (2007) 1.13
Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. J Virol (2009) 0.97
Managing pediatric hepatitis C: current and emerging treatment options. Ther Clin Risk Manag (2009) 0.90
Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells. Apoptosis (2011) 0.81
Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice. J Virol Methods (2007) 0.80
Expression of hepatitis B virus x protein in hepatocytes suppresses CD8 T cell activity. Immune Netw (2010) 0.80
Apoptosis - an Ubiquitous T cell Immunomodulator. J Clin Cell Immunol (2011) 0.75
Assessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients. Mem Inst Oswaldo Cruz (2014) 0.75
Hepatitis C Virus Infection of Cultured Human Hepatoma Cells Causes Apoptosis and Pyroptosis in Both Infected and Bystander Cells. Sci Rep (2016) 0.75
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05
Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med (2000) 9.36
Lethal effect of the anti-Fas antibody in mice. Nature (1993) 9.20
Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (1994) 7.34
Analysis of a successful immune response against hepatitis C virus. Immunity (1999) 6.31
Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med (2000) 5.27
HCV persistence and immune evasion in the absence of memory T cell help. Science (2003) 5.23
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med (2000) 4.98
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet (1995) 4.71
Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med (2003) 4.20
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest (1996) 4.10
Fas ligand-induced apoptosis. Annu Rev Genet (1999) 3.59
CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol (2000) 3.36
A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol (1999) 3.36
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
Reversal of transplantation immunity by liver grafting. Nature (1981) 3.07
Hepatocyte proliferation in vitro: its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc Natl Acad Sci U S A (1984) 2.64
Mouse liver cell culture. I. Hepatocyte isolation. In Vitro (1981) 2.50
Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology (2001) 2.49
Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol (1999) 2.44
Selective retention of activated CD8+ T cells by the normal liver. J Immunol (1999) 2.23
The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev (2000) 2.13
The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity (1994) 2.11
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81
TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur J Immunol (1998) 1.81
Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology (1994) 1.80
Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J Immunol (1999) 1.73
Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells. J Immunol (2004) 1.64
Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression. J Virol (1999) 1.63
Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity. J Hepatol (2001) 1.61
Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol (1998) 1.54
Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol (1995) 1.40
Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun (1994) 1.39
Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci U S A (1998) 1.34
Passive and active mechanisms trap activated CD8+ T cells in the liver. J Immunol (2004) 1.27
Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. Eur J Immunol (2000) 1.24
Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med (1995) 1.24
The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C. J Mol Med (Berl) (1996) 1.14
Flow cytometric analysis of apoptotic subpopulations with a combination of annexin V-FITC, propidium iodide, and SYTO 17. Cytometry (2001) 1.13
TCR ligation on CD8+ T cells creates double-negative cells in vivo. J Immunol (1998) 1.12
Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeys. J Immunol (2000) 1.05
Fas and other cell death signaling pathways. Semin Immunol (1997) 1.04
Comparison of seven quantitative assays to assess lymphocyte cell death during HIV infection: measurement of induced apoptosis in anti-Fas-treated Jurkat cells and spontaneous apoptosis in peripheral blood mononuclear cells from children infected with HIV. AIDS Res Hum Retroviruses (1998) 1.00
Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology (1997) 0.99
Multiple sites of post-activation CD8+ T cell disposal. Eur J Immunol (1997) 0.97
Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity. J Virol (2002) 0.94
Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection. J Virol (2001) 0.94
TNF-alpha controls intrahepatic T cell apoptosis and peripheral T cell numbers. J Immunol (2004) 0.90
Death and destruction of activated T lymphocytes. Immunol Res (1999) 0.85
Magnitude of activity in chronic hepatitis C is influenced by apoptosis of T cells responsible for hepatitis C virus. J Gastroenterol Hepatol (1999) 0.82
Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis. J Clin Immunol (2000) 0.81
Induction of FAS ligand expression in a human hepatoblastoma cell line by HCV core protein. Virus Res (2003) 0.80
Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br J Haematol (2000) 0.80
The two-way paradigm of transplantation immunology. Clin Immunol Immunopathol (1996) 0.78
Towards a reliable parameter of liver damage in hepatitis C: TUNEL versus caspase activation. Hepatology (2001) 0.77
Apoptosis of alloreactive T cells in liver allografts during tolerance induction. Transplant Proc (1999) 0.76
Epidemiology of anesthesia-related mortality in the United States, 1999-2005. Anesthesiology (2009) 3.00
Contemporary epidemiology and characterization of newborn males with prune belly syndrome. Urology (2010) 2.30
Gender assignment for newborns with 46XY cloacal exstrophy: a 6-year followup survey of pediatric urologists. J Urol (2011) 2.11
Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis (2005) 2.06
Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology (2005) 1.87
Oxygen isotope anomaly observed in water vapor from Alert, Canada and the implication for the stratosphere. Proc Natl Acad Sci U S A (2013) 1.78
Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone (2007) 1.77
Shock wave lithotripsy vs ureteroscopy: variation in surgical management of kidney stones at freestanding children's hospitals. J Urol (2012) 1.53
Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol (2002) 1.52
Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics. Hepatology (2004) 1.51
hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol Cell Biol (2005) 1.50
To be or not to be NKT: natural killer T cells in the liver. Hepatology (2004) 1.49
Long-term incidence of urinary tract infection after ureteral reimplantation for primary vesicoureteral reflux. J Pediatr Urol (2012) 1.48
A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen (2007) 1.44
Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene (2002) 1.43
Durability of antireflux effect of ureteral reimplantation for primary vesicoureteral reflux: findings on long-term cystography. Urology (2012) 1.39
Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology (2006) 1.30
Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol (2004) 1.25
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. J Infect Dis (2006) 1.19
Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology (2004) 1.19
Familial neuralgia of occipital and intermedius nerves in a Chinese family. J Headache Pain (2011) 1.17
Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol (2007) 1.13
Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression. Cancer Res (2006) 1.11
Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection. Clin Infect Dis (2004) 1.11
Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion. Pharm Res (2011) 1.09
HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood (2004) 1.08
A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J Biol Chem (2010) 1.08
Hypertrophic response and keloid diathesis: two very different forms of scar. Plast Reconstr Surg (2005) 1.07
Applications of diffusion-weighted MRI in thoracic spinal cord injury without radiographic abnormality. Int Orthop (2006) 1.07
c-myc Repression of TSC2 contributes to control of translation initiation and Myc-induced transformation. Cancer Res (2007) 1.07
First things first: balancing hepatitis C and human immunodeficiency virus. Clin Infect Dis (2003) 1.06
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C. Hepatology (2005) 1.05
Safety of influenza vaccine administration in egg-allergic patients. Pediatrics (2010) 1.04
Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol (2003) 1.03
The molecular recognition of kink-turn structure by the L7Ae class of proteins. RNA (2013) 1.02
Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth. J Biol Chem (2003) 1.02
Genome-wide analysis of YY2 versus YY1 target genes. Nucleic Acids Res (2010) 1.01
DNA methylation in oocytes and liver of female mice and their offspring: effects of high-fat-diet-induced obesity. Environ Health Perspect (2013) 1.00
High-dose mannose-binding lectin therapy for Ebola virus infection. J Infect Dis (2011) 0.99
The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancers. Cancer Res (2010) 0.99
Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology (2005) 0.99
The MTAP-CDKN2A locus confers susceptibility to a naturally occurring canine cancer. Cancer Epidemiol Biomarkers Prev (2012) 0.98
Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. Connect Tissue Res (2013) 0.97
Site-specific proteomics approach for study protein S-nitrosylation. Anal Chem (2010) 0.97
Different fates of oocytes with DNA double-strand breaks in vitro and in vivo. Cell Cycle (2014) 0.96
Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin Exp Pharmacol Physiol (2007) 0.96
Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther (2011) 0.96
Notch signaling is involved in ovarian follicle development by regulating granulosa cell proliferation. Endocrinology (2011) 0.95
CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. J Infect Dis (2005) 0.94
Quality of life in children with vesicoureteral reflux as perceived by children and parents. J Pediatr Urol (2011) 0.94
HIV and liver disease forum: conference proceedings. Hepatology (2007) 0.93
Immune responses during acute and chronic infection with hepatitis C virus. Clin Immunol (2008) 0.92
Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. Mol Cell Biol (2010) 0.91
Translational repression by the oocyte-specific protein P100 in Xenopus. Dev Biol (2010) 0.91
Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics. BMC Cancer (2013) 0.91
Cytochemical and ultrastructural changes in the osteoclast-like giant cells of giant cell tumor of bone following bisphosphonate administration. Ultrastruct Pathol (2003) 0.91
Regulation of VH replacement by B cell receptor-mediated signaling in human immature B cells. J Immunol (2013) 0.90
Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol (2010) 0.90
UNiquant, a program for quantitative proteomics analysis using stable isotope labeling. J Proteome Res (2011) 0.90
Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosage. Anesthesiology (2006) 0.90
Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis. Endocrinology (2009) 0.90
Complex network synchronizability: analysis and control. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 0.90
Forced expression of cyclin D1 does not compensate for Id2 deficiency in the mammary gland. FEBS Lett (2003) 0.90
CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression. J Cell Biochem (2010) 0.89
Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS (2005) 0.89
Cyclin B3 controls anaphase onset independent of spindle assembly checkpoint in meiotic oocytes. Cell Cycle (2015) 0.89
Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C. Liver Int (2006) 0.89
Introgression mapping in the grasses. Chromosome Res (2007) 0.88
Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells. Mol Cancer (2014) 0.88
Increased smooth muscle contractility in mice deficient for neuropilin 2. Am J Pathol (2012) 0.88
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer. Am J Pathol (2004) 0.88
Epidermal growth factor receptor expression is a candidate target of the synergistic combination of trastuzumab and flavopiridol in breast cancer. Cancer Res (2003) 0.88
Rate-limiting effects of Cyclin D1 in transformation by ErbB2 predicts synergy between herceptin and flavopiridol. Cancer Res (2002) 0.88
CD9 is critical for cutaneous wound healing through JNK signaling. J Invest Dermatol (2011) 0.87
DDPH ameliorated oxygen and glucose deprivation-induced injury in rat hippocampal neurons via interrupting Ca2+ overload and glutamate release. Eur J Pharmacol (2008) 0.87
Pulsed electromagnetic fields (PEMF) promote early wound healing and myofibroblast proliferation in diabetic rats. Bioelectromagnetics (2014) 0.86
Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. J Interferon Cytokine Res (2006) 0.86
Reactivation of hepatitis C viral infection after treatment with infliximab. J Clin Gastroenterol (2014) 0.86
Evolution of plant senescence. BMC Evol Biol (2009) 0.86
Thermal stability and in vitro bioactivity of Ti-Al-V-O nanostructures fabricated on Ti6Al4V alloy. Nanotechnology (2009) 0.85
A new ERK2 binding protein, Naf1, attenuates the EGF/ERK2 nuclear signaling. Biochem Biophys Res Commun (2002) 0.85
Bioinformatics in the orphan crops. Brief Bioinform (2009) 0.85
Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial. Cell Transplant (2013) 0.85
Patchy distributions of competitors affect the growth of a clonal plant when the competitor density is high. PLoS One (2013) 0.84
The impact of discrete modes of spinal cord injury on bladder muscle contractility. BMC Urol (2013) 0.84
Anti-hyperglycemic, antioxidant and anti-inflammatory effects of VIP and a VPAC1 agonist on streptozotocin-induced diabetic mice. Peptides (2010) 0.84
Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone. J Orthop Res (2010) 0.83
A novel cyclopeptide from the cyclization of PACAP(1-5) with potent activity towards PAC1 attenuates STZ-induced diabetes. Peptides (2010) 0.83
MBTD1 is associated with Pr-Set7 to stabilize H4K20me1 in mouse oocyte meiotic maturation. Cell Cycle (2013) 0.83
The k-junction motif in RNA structure. Nucleic Acids Res (2014) 0.83
Viral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res (2007) 0.83
Specific deletion of Cdc42 does not affect meiotic spindle organization/migration and homologous chromosome segregation but disrupts polarity establishment and cytokinesis in mouse oocytes. Mol Biol Cell (2013) 0.83
Specifically expressed genes of the nematode Bursaphelenchus xylophilus involved with early interactions with pine trees. PLoS One (2013) 0.83
Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant. Cancer Res (2006) 0.83
Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China. J Clin Microbiol (2010) 0.83
Structural and functional analysis of validoxylamine A 7'-phosphate synthase ValL involved in validamycin A biosynthesis. PLoS One (2012) 0.83
[Effects of Xiaoyao Wan on the behavioral despair and stress depression mice]. Zhong Yao Cai (2008) 0.82
NK cells: natural born killers in the conflict between humans and HCV. Hepatology (2006) 0.82
Protein modifications by electrophilic lipoxidation products: adduct formation, chemical strategies and tandem mass spectrometry for their detection and identification. Mass Spectrom Rev (2014) 0.82
Tunable Luminescent Properties and Concentration-Dependent, Site-Preferable Distribution of Eu(2+) Ions in Silicate Glass for White LEDs Applications. ACS Appl Mater Interfaces (2015) 0.82